On Monday 28 January, the European Commission published a report on the application of EU competition law rules in the pharmaceutical sector since 2009, which shows that effective enforcement of these rules ensures access to affordable and innovative medicines for European citizens.
The final document is the result of joint work by the institution and the national competition authorities and takes stock of the decisions taken by the Commission with regard to pharmaceutical companies.